Increasing Awareness and Perception of Heart Failure in Europe and Improving Care—Rationale and Design of the SHAPE Study

By Remme Willem   Boccanelli Alessandro   Cline Charles   Cohen-Solal Alain   Dietz Rainer   Hobbs Richard   Keukelaar Karen   Sendon Jose   Macarie Cezar   McMurray John   Rauch Bernhard   Ruzyllo Witold   Zannad Faiez  

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 2, 2004-03 ,pp. : 153-159

Springer Publishing Company

Access to resources Recommend Favorite

Rationale and Design of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy for Heart Failure (IMPACT-HF) Study

By  

Heart Drug, Vol. 2, Iss. 4, 2002-11 ,pp. : 164-166

Karger

Access to resources Recommend Favorite

The Case-Population Study Design: An Analysis of its Application in Pharmacovigilance

By Théophile Hélène   Laporte Joan-Ramon   Moore Nicholas   Martin Karin-Latry   Bégaud Bernard  

Drug Safety, Vol. 34, Iss. 10, 2011-10 ,pp. : 861-868

Adis International

Access to resources Recommend Favorite

Rationale, design and organisation of an efficacy and safety study of oxypurinol added to standard therapy in patients with NYHA class III – IV congestive heart failure

By Freudenberger Ronald S   Schwarz Jr Richard P   Brown Joanne   Moore Alan   Mann Douglas   Givertz Michael M   Colucci Wilson S   Hare Joshua M  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 11, 2004-11 ,pp. : 1509-1516

Informa Healthcare

Access to resources Recommend Favorite

Hospital discharges and 30-day case fatality for drug poisoning: a Danish population-based study from 1979 to 2002 with special emphasis on paracetamol

By Møller Lene   Nielsen Gunnar   Olsen Mette   Thulstrup Ane   Mortensen Jens   Sørensen Henrik  

European Journal of Clinical Pharmacology, Vol. 59, Iss. 12, 2004-02 ,pp. : 911-915

Springer Publishing Company

Access to resources Recommend Favorite